Article 13 Aug 2026 CAFC Reverses Jury Decision In Board Of Regents Of The University Of Texas System v. Boston Scientific Corp. United States IP
Article 17 Mar 2026 REGENXBIO, Inc. v. Sarepta Therapeutics: Recombinant DNA Molecule Patent-Eligibility Under 35 U.S.C. § 101 United States IP
Article 28 Jul 2025 Eye Therapies, LLC. v. Slayback Pharma, LLC: How Prosecution History Can Alter Phrase Interpretation United States IP
Article 13 Mar 2025 US Synthetic Corp. v. International Trade Commission: Safeguarding Structure And Property Limitations In Composition-of-Matter Claims United States Healthcare